SGLT-2 inhibitors are a relatively new class of diabetes drugs that have shown many benefits for people with type 2 diabetes who have not responded well to previous interventions, including diet changes and metformin. Patients ...
Mar 7, 2019
0
35
It's well-known that exercise improves health, but understanding how it makes you healthier on a molecular level is the question researchers at Joslin Diabetes Center are answering.
Feb 11, 2019
0
2321
Scientists continue to find evidence linking Type 2 diabetes with Alzheimer's disease, the most common form of dementia and the seventh leading cause of death in the United States. However, little is understood about the ...
Feb 11, 2019
0
789
People with type 1 diabetes are far more likely to develop cardiovascular disease than those without diabetes. Their risks climb even higher if they show signs of hypertension (high blood pressure) or dyslipidemia (unhealthy ...
Oct 11, 2018
0
8
Type 2 diabetes is driven by many metabolic pathways, with some pathways driven by amino acids, the molecular building blocks for proteins. Scientists at Joslin Diabetes Center now have shown that one amino acid, alanine, ...
Oct 10, 2018
0
1
Coronary artery disease (CAD) is the leading killer of people with type 2 diabetes, and it's not a secret killer.
Sep 27, 2018
0
0
Some people respond well to both aerobic exercise and strength training, while others don't. And some of us respond well to only one of those things, but not both. Scientists at Joslin Diabetes Center now have uncovered a ...
Aug 2, 2018
0
605
Like everyone, people with type 2 diabetes and obesity suffer from depression and anxiety, but even more so. Researchers at Joslin Diabetes Center now have demonstrated a surprising potential contributor to these negative ...
Jun 18, 2018
0
487
Managing type 1diabetes during the first two decades of life is challenging. Insulin requirements change along with the stages of life —- childhood, puberty, young adulthood, and beyond. But a 20-year longitudinal study ...
Jun 6, 2018
0
0
People who live with type 1 diabetes for very long duration show signs of mild decreases in cognitive abilities, primarily in memory, compared to those who don't have the disease, Joslin Diabetes Center researchers have shown.
Jun 5, 2018
0
9
